• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症的发生、发展和对治疗的反应是通过限制蛋白质-蛋白质相互作用网络的扰动来实现的。

Cancer develops, progresses and responds to therapies through restricted perturbation of the protein-protein interaction network.

机构信息

Translational Research Laboratory, Breast Cancer Unit, Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), Gran via 199, L'Hospitalet del Llobregat, Barcelona 08908, Catalonia, Spain.

出版信息

Integr Biol (Camb). 2012 Sep;4(9):1038-48. doi: 10.1039/c2ib20052j. Epub 2012 Jul 18.

DOI:10.1039/c2ib20052j
PMID:22806580
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4699251/
Abstract

The products of genes mutated or differentially expressed in cancer tend to occupy central positions within the network of protein-protein interactions, or the interactome network. Integration of different types of gene and protein relationships has considerably increased the understanding of the mechanisms of carcinogenesis, while also enhancing the applicability of expression signatures. In this scenario, however, it remains unknown how cancer develops, progresses and responds to therapies in a potentially controlled manner at the systems level. Here, by applying the concepts of load transfer and cascading failures in power grids, we examine the impact and transmission of cancer-related gene expression changes in the interactome network. Relative to random perturbations, this study reveals topological robustness associated with all cancer conditions. In addition, experimental perturbation of a central cancer node, which consists of over-expression of the α-synuclein (SNCA) protein in MCF7 breast cancer cells, also reveals robustness. Conversely, a search for proteins with an opposite topological impact identifies the autophagy pathway. Mechanistically, the existence of smaller shortest paths among cancer-related proteins appears to be a topological feature that partially contributes to the restricted perturbation of the network. Together, the results of this study suggest that cancer develops, progresses and responds to therapies following controlled, restricted perturbation of the interactome network.

摘要

在癌症中发生突变或差异表达的基因产物往往占据蛋白质-蛋白质相互作用网络(即互作网络)的核心位置。不同类型的基因和蛋白质关系的整合极大地提高了对致癌机制的理解,同时也增强了表达谱的适用性。然而,在这种情况下,人们仍然不知道癌症如何在系统水平上以潜在可控的方式发展、进展和对治疗做出反应。在这里,我们通过应用电网中的负载转移和级联故障的概念,研究了互作网络中与癌症相关的基因表达变化的影响和传递。与随机扰动相比,本研究揭示了与所有癌症情况相关的拓扑鲁棒性。此外,对中央癌症节点的实验扰动,即 MCF7 乳腺癌细胞中α-突触核蛋白(SNCA)的过表达,也显示出了鲁棒性。相反,寻找具有相反拓扑影响的蛋白质可以确定自噬途径。从机制上讲,癌症相关蛋白质之间存在较短的最短路径似乎是网络受到限制的部分原因。总之,这项研究的结果表明,癌症的发展、进展和对治疗的反应遵循互作网络的受控、受限扰动。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ce/4699251/0ef3352b3a7c/c2ib20052j-f10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ce/4699251/ff8a9a879c13/c2ib20052j-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ce/4699251/4c7ecd5f4af2/c2ib20052j-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ce/4699251/34c418197f8c/c2ib20052j-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ce/4699251/9d0ed60df4b2/c2ib20052j-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ce/4699251/a8582aa434fc/c2ib20052j-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ce/4699251/d175e8ad68de/c2ib20052j-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ce/4699251/ef220d480631/c2ib20052j-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ce/4699251/9d30f26975e9/c2ib20052j-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ce/4699251/860b8b9400fd/c2ib20052j-f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ce/4699251/0ef3352b3a7c/c2ib20052j-f10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ce/4699251/ff8a9a879c13/c2ib20052j-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ce/4699251/4c7ecd5f4af2/c2ib20052j-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ce/4699251/34c418197f8c/c2ib20052j-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ce/4699251/9d0ed60df4b2/c2ib20052j-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ce/4699251/a8582aa434fc/c2ib20052j-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ce/4699251/d175e8ad68de/c2ib20052j-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ce/4699251/ef220d480631/c2ib20052j-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ce/4699251/9d30f26975e9/c2ib20052j-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ce/4699251/860b8b9400fd/c2ib20052j-f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ce/4699251/0ef3352b3a7c/c2ib20052j-f10.jpg

相似文献

1
Cancer develops, progresses and responds to therapies through restricted perturbation of the protein-protein interaction network.癌症的发生、发展和对治疗的反应是通过限制蛋白质-蛋白质相互作用网络的扰动来实现的。
Integr Biol (Camb). 2012 Sep;4(9):1038-48. doi: 10.1039/c2ib20052j. Epub 2012 Jul 18.
2
Network topology measures for identifying disease-gene association in breast cancer.用于识别乳腺癌中疾病-基因关联的网络拓扑测量方法。
BMC Bioinformatics. 2016 Jul 25;17 Suppl 7(Suppl 7):274. doi: 10.1186/s12859-016-1095-5.
3
Comparative analysis of protein interactome networks prioritizes candidate genes with cancer signatures.蛋白质相互作用组网络的比较分析对具有癌症特征的候选基因进行了优先排序。
Oncotarget. 2016 Nov 29;7(48):78841-78849. doi: 10.18632/oncotarget.12879.
4
Reconstruction and signal propagation analysis of the Syk signaling network in breast cancer cells.乳腺癌细胞中Syk信号网络的重建与信号传播分析
PLoS Comput Biol. 2017 Mar 17;13(3):e1005432. doi: 10.1371/journal.pcbi.1005432. eCollection 2017 Mar.
5
Network Properties of Cancer Prognostic Gene Signatures in the Human Protein Interactome.人类蛋白质互作网络中癌症预后基因特征的网络特性。
Genes (Basel). 2020 Feb 26;11(3):247. doi: 10.3390/genes11030247.
6
Cancer network activity associated with therapeutic response and synergism.与治疗反应和协同作用相关的癌症网络活性。
Genome Med. 2016 Aug 24;8(1):88. doi: 10.1186/s13073-016-0340-x.
7
Incorporating topological information for predicting robust cancer subnetwork markers in human protein-protein interaction network.整合拓扑信息以预测人类蛋白质-蛋白质相互作用网络中稳健的癌症子网标志物。
BMC Bioinformatics. 2016 Oct 6;17(Suppl 13):351. doi: 10.1186/s12859-016-1224-1.
8
The New Paradigm of Network Medicine to Analyze Breast Cancer Phenotypes.网络医学分析乳腺癌表型的新模式。
Int J Mol Sci. 2020 Sep 12;21(18):6690. doi: 10.3390/ijms21186690.
9
Systematic identification of molecular links between core and candidate genes in breast cancer.系统鉴定乳腺癌核心基因和候选基因之间的分子联系。
J Mol Biol. 2015 Mar 27;427(6 Pt B):1436-1450. doi: 10.1016/j.jmb.2015.01.014. Epub 2015 Jan 29.
10
Ligand-activated progesterone receptor B activates transcription factor EB to promote autophagy in human breast cancer cells.配体激活的孕激素受体 B 激活转录因子 EB 以促进人乳腺癌细胞的自噬。
Exp Cell Res. 2019 Sep 1;382(1):111433. doi: 10.1016/j.yexcr.2019.05.014. Epub 2019 May 14.

引用本文的文献

1
Dysregulated lncRNA-miRNA-mRNA Network Reveals Patient Survival-Associated Modules and RNA Binding Proteins in Invasive Breast Carcinoma.失调的lncRNA-miRNA-mRNA网络揭示了浸润性乳腺癌中与患者生存相关的模块和RNA结合蛋白。
Front Genet. 2020 Jan 15;10:1284. doi: 10.3389/fgene.2019.01284. eCollection 2019.
2
Cancer network activity associated with therapeutic response and synergism.与治疗反应和协同作用相关的癌症网络活性。
Genome Med. 2016 Aug 24;8(1):88. doi: 10.1186/s13073-016-0340-x.
3
Targets of drugs are generally, and targets of drugs having side effects are specifically good spreaders of human interactome perturbations.

本文引用的文献

1
Autophagy as a target for anticancer therapy.自噬作为抗癌治疗的靶点。
Nat Rev Clin Oncol. 2011 May 17;8(9):528-39. doi: 10.1038/nrclinonc.2011.71.
2
Integrative gene network construction for predicting a set of complementary prostate cancer genes.综合基因网络构建用于预测一组互补的前列腺癌基因。
Bioinformatics. 2011 Jul 1;27(13):1846-53. doi: 10.1093/bioinformatics/btr283. Epub 2011 May 6.
3
Functional synergies yet distinct modulators affected by genetic alterations in common human cancers.在常见人类癌症中,基因改变影响功能协同但不同的调节剂。
药物靶点通常如此,而具有副作用的药物靶点则尤其会成为人类相互作用组扰动的良好传播者。
Sci Rep. 2015 May 11;5:10182. doi: 10.1038/srep10182.
4
Increased signaling entropy in cancer requires the scale-free property of protein interaction networks.癌症中增加的信号熵需要蛋白质相互作用网络的无标度特性。
Sci Rep. 2015 Apr 28;5:9646. doi: 10.1038/srep09646.
5
Integrative analysis of cancer imaging readouts by networks.通过网络对癌症影像读数进行综合分析。
Mol Oncol. 2015 Jan;9(1):1-16. doi: 10.1016/j.molonc.2014.08.013. Epub 2014 Sep 10.
6
Structure and dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive review.分子网络的结构与动态:药物发现的新范例:全面综述。
Pharmacol Ther. 2013 Jun;138(3):333-408. doi: 10.1016/j.pharmthera.2013.01.016. Epub 2013 Feb 4.
Cancer Res. 2011 May 15;71(10):3471-81. doi: 10.1158/0008-5472.CAN-10-3038. Epub 2011 Mar 11.
4
Hallmarks of cancer: the next generation.癌症的特征:下一代。
Cell. 2011 Mar 4;144(5):646-74. doi: 10.1016/j.cell.2011.02.013.
5
Statistical analysis of the cancer cell's molecular entropy using high-throughput data.利用高通量数据对癌细胞分子熵进行统计分析。
Bioinformatics. 2011 Feb 15;27(4):556-63. doi: 10.1093/bioinformatics/btq704. Epub 2010 Dec 20.
6
Network medicine: a network-based approach to human disease.网络医学:一种基于网络的人类疾病研究方法。
Nat Rev Genet. 2011 Jan;12(1):56-68. doi: 10.1038/nrg2918.
7
Regulation patterns in signaling networks of cancer.癌症信号网络中的调控模式。
BMC Syst Biol. 2010 Nov 26;4:162. doi: 10.1186/1752-0509-4-162.
8
Identification of high-quality cancer prognostic markers and metastasis network modules.鉴定高质量的癌症预后标志物和转移网络模块。
Nat Commun. 2010 Jul 13;1(4):34. doi: 10.1038/ncomms1033.
9
Increased entropy of signal transduction in the cancer metastasis phenotype.癌症转移表型中信号转导的熵增加。
BMC Syst Biol. 2010 Jul 30;4:104. doi: 10.1186/1752-0509-4-104.
10
Natural immunity to cancer in humans.人类对癌症的天然免疫力。
Curr Opin Immunol. 2010 Apr;22(2):215-22. doi: 10.1016/j.coi.2010.02.006. Epub 2010 Mar 6.